166 related articles for article (PubMed ID: 31102011)
1. An essential role for GLUT5-mediated fructose utilization in exacerbating the malignancy of clear cell renal cell carcinoma.
Jin X; Liang Y; Liu D; Luo Q; Cai L; Wu J; Jia L; Chen WL
Cell Biol Toxicol; 2019 Oct; 35(5):471-483. PubMed ID: 31102011
[TBL] [Abstract][Full Text] [Related]
2. GLUT5-mediated fructose utilization drives lung cancer growth by stimulating fatty acid synthesis and AMPK/mTORC1 signaling.
Chen WL; Jin X; Wang M; Liu D; Luo Q; Tian H; Cai L; Meng L; Bi R; Wang L; Xie X; Yu G; Li L; Dong C; Cai Q; Jia W; Wei W; Jia L
JCI Insight; 2020 Feb; 5(3):. PubMed ID: 32051337
[TBL] [Abstract][Full Text] [Related]
3. GLUT5 increases fructose utilization and promotes tumor progression in glioma.
Su C; Li H; Gao W
Biochem Biophys Res Commun; 2018 Jun; 500(2):462-469. PubMed ID: 29660339
[TBL] [Abstract][Full Text] [Related]
4. Enhanced Fructose Utilization Mediated by SLC2A5 Is a Unique Metabolic Feature of Acute Myeloid Leukemia with Therapeutic Potential.
Chen WL; Wang YY; Zhao A; Xia L; Xie G; Su M; Zhao L; Liu J; Qu C; Wei R; Rajani C; Ni Y; Cheng Z; Chen Z; Chen SJ; Jia W
Cancer Cell; 2016 Nov; 30(5):779-791. PubMed ID: 27746145
[TBL] [Abstract][Full Text] [Related]
5. Fructose transporter GLUT5 expression in clear renal cell carcinoma.
Medina Villaamil V; Aparicio Gallego G; Valbuena Rubira L; García Campelo R; Valladares-Ayerbes M; Grande Pulido E; Victoria Bolós M; Santamarina Caínzos I; Antón Aparicio LM
Oncol Rep; 2011 Feb; 25(2):315-23. PubMed ID: 21165569
[TBL] [Abstract][Full Text] [Related]
6. Identification of the fructose transporter GLUT5 (SLC2A5) as a novel target of nuclear receptor LXR.
Zwarts I; van Zutphen T; Kruit JK; Liu W; Oosterveer MH; Verkade HJ; Uhlenhaut NH; Jonker JW
Sci Rep; 2019 Jun; 9(1):9299. PubMed ID: 31243309
[TBL] [Abstract][Full Text] [Related]
7. Radiopharmacological evaluation of 6-deoxy-6-[18F]fluoro-D-fructose as a radiotracer for PET imaging of GLUT5 in breast cancer.
Wuest M; Trayner BJ; Grant TN; Jans HS; Mercer JR; Murray D; West FG; McEwan AJ; Wuest F; Cheeseman CI
Nucl Med Biol; 2011 May; 38(4):461-75. PubMed ID: 21531283
[TBL] [Abstract][Full Text] [Related]
8. Fructose utilization enhanced by GLUT5 promotes lung cancer cell migration via activating glycolysis/AKT pathway.
Yang J; Dong C; Wu J; Liu D; Luo Q; Jin X
Clin Transl Oncol; 2023 Apr; 25(4):1080-1090. PubMed ID: 36454516
[TBL] [Abstract][Full Text] [Related]
9. Expression and function of hexose transporters GLUT1, GLUT2, and GLUT5 in breast cancer-effects of hypoxia.
Hamann I; Krys D; Glubrecht D; Bouvet V; Marshall A; Vos L; Mackey JR; Wuest M; Wuest F
FASEB J; 2018 Sep; 32(9):5104-5118. PubMed ID: 29913554
[TBL] [Abstract][Full Text] [Related]
10. Molecular Imaging of GLUT1 and GLUT5 in Breast Cancer: A Multitracer Positron Emission Tomography Imaging Study in Mice.
Wuest M; Hamann I; Bouvet V; Glubrecht D; Marshall A; Trayner B; Soueidan OM; Krys D; Wagner M; Cheeseman C; West F; Wuest F
Mol Pharmacol; 2018 Feb; 93(2):79-89. PubMed ID: 29142019
[TBL] [Abstract][Full Text] [Related]
11. Identification of essential amino acids for glucose transporter 5 (GLUT5)-mediated fructose transport.
Ebert K; Ewers M; Bisha I; Sander S; Rasputniac T; Daniel H; Antes I; Witt H
J Biol Chem; 2018 Feb; 293(6):2115-2124. PubMed ID: 29259131
[TBL] [Abstract][Full Text] [Related]
12. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
[TBL] [Abstract][Full Text] [Related]
13. d-Allulose is a substrate of glucose transporter type 5 (GLUT5) in the small intestine.
Kishida K; Martinez G; Iida T; Yamada T; Ferraris RP; Toyoda Y
Food Chem; 2019 Mar; 277():604-608. PubMed ID: 30502192
[TBL] [Abstract][Full Text] [Related]
14. Diet-induced epigenetic regulation in vivo of the intestinal fructose transporter Glut5 during development of rat small intestine.
Suzuki T; Douard V; Mochizuki K; Goda T; Ferraris RP
Biochem J; 2011 Apr; 435(1):43-53. PubMed ID: 21222652
[TBL] [Abstract][Full Text] [Related]
15. Characterization of the rabbit intestinal fructose transporter (GLUT5).
Miyamoto K; Tatsumi S; Morimoto A; Minami H; Yamamoto H; Sone K; Taketani Y; Nakabou Y; Oka T; Takeda E
Biochem J; 1994 Nov; 303 ( Pt 3)(Pt 3):877-83. PubMed ID: 7980458
[TBL] [Abstract][Full Text] [Related]
16. GLUT5-KHK axis-mediated fructose metabolism drives proliferation and chemotherapy resistance of colorectal cancer.
Shen Z; Li Z; Liu Y; Li Y; Feng X; Zhan Y; Lin M; Fang C; Fang Y; Deng H
Cancer Lett; 2022 May; 534():215617. PubMed ID: 35257833
[TBL] [Abstract][Full Text] [Related]
17. Targeting of GLUT5 for Transporter-Mediated Drug-Delivery Is Contingent upon Substrate Hydrophilicity.
Nahrjou N; Ghosh A; Tanasova M
Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34064801
[TBL] [Abstract][Full Text] [Related]
18. New fluorinated fructose analogs as selective probes of the hexose transporter protein GLUT5.
Soueidan OM; Trayner BJ; Grant TN; Henderson JR; Wuest F; West FG; Cheeseman CI
Org Biomol Chem; 2015 Jun; 13(23):6511-21. PubMed ID: 25975431
[TBL] [Abstract][Full Text] [Related]
19. Fluorescent THF-based fructose analogue exhibits fructose-dependent uptake.
Tanasova M; Plutschack M; Muroski ME; Sturla SJ; Strouse GF; McQuade DT
Chembiochem; 2013 Jul; 14(10):1263-70. PubMed ID: 23784717
[TBL] [Abstract][Full Text] [Related]
20. NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma.
Wang Q; Ding H; He Y; Li X; Cheng Y; Xu Q; Yang Y; Liao G; Meng X; Huang C; Li J
Cancer Lett; 2019 Mar; 444():9-19. PubMed ID: 30543814
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
